FDA-PDS Symposium III: Intermediate Endpoints in Immuno-Oncology Keynote The Role of Data Sharing in Fulfilling FDA’s Vision of an Evidence Generation System Robert M. Califf, MD, Commissioner, FDA Main sessions Project Data Sphere Initiative Update: Outcomes Since Symposium II [...]
FDA-PDS Symposium IV: Project Data Sphere, LLC & NCTN Data Archive Initiative Keynote The Promise of Shared Data Janet Woodcock, MD, Director, Center for Drug Evaluation and Research, FDA Main Sessions Leveraging the Power of Collaboration: FDA's New Oncology Center [...]
FDA-PDS Symposium V: Growing Dimensions of Big Data in Cancer Research Executive Summary Keynote The Potential and Reality of Data Sharing in Fulfilling the FDA Vision of an Evidence-Generation System Sean Khozin, MD, MPH, Associate Director (Acting), FDA Oncology [...]
Symposium VI: Small Cell Lung Cancer (SCLC) External Control Arm: A Paradigm Shift in Cancer Drug Evaluation/Registration Executive Summary Keynotes Patient-Centered Datasharing: An Imperative for Agile Innovation Paul Howard, PhD, Senior Advisor to the Commissioner, FDA NCI Clinical Data [...]
FDA-PDS Symposium VII: Immune-Related Adverse Events and Checkpoint Blockade Combination Therapies Keynote Current Clinical Challenges in Immune-Related Adverse Events and Emerging Opportunities: The MGH Experience Kerry Reynolds, MD, Director of the Severe Immunotherapy Complications Service and Clinical Director, [...]
FDA-PDS Symposium VIII: Artificial Intelligence in Tumor Imaging: Needs, Opportunities & Challenges Executive Summary Goals and Objectives Five years ago the CEO Roundtable on Cancer's Project Data Sphere® (PDS), in partnership with the FDA, founded a series of symposia [...]
Executive Summary PDS Symposium IX on rare cancer registries was a virtual meeting held on Oct. 7, 2020. For the first time in our annual symposia series, we are met online. As a result, more of you were able to engage which will help [...]
Teilo hosted the irAE symposium to share the progress and discuss future directions for the irAE field. Introduction and Opening Remarks Introduced to Project Data Sphere (PDS) and the event’s program; Presented overview of the landscape around ICIs and [...]
Executive Summary Overview: For the last 6 years, the CEO Roundtable on Cancer’s Project Data Sphere (PDS) has actively partnered with the FDA through a series of symposia focused on building consensus within the scientific community in support of advanced [...]
ACCELERATE HEALTH was the focus of the CEO Roundtable on Cancer’s Annual Conference on November 17, 2021. Reflecting the theme, the event was broadcast from the Ingram Collection of memorable Porsche sportscars with our host, Founding CEO Roundtable on [...]
After two years of virtual events, the 2022 CEO Roundtable on Cancer Annual Meeting and Conference was held Nov. 1-2 on the campus of SAS Institute in Cary, NC. CEOs and other leaders gathered to discuss the state of cancer research, policy and advocacy, recruitment and retention, benefits, and wellness.
The 2024 CEO Roundtable on Cancer Annual Meeting is now the 2024 Partnership Summit The Summit will still feature panels on how we are reimagining oncology clinical trials with our members and partners. We look forward to seeing you, hearing from you, and […]
